長期投資家のためのIR情報
バリュートレンド

【4578】大塚ホールディングス
製薬。抗精神病。機能性食品『ポカリスエット』など。
類似企業:
【業界1位】 武田薬品工業
【売上同水準】 アステラス製薬 第一三共

売上高
営業利益
経常利益
当期利益
{{models[key].tabname}}
決算期 日付 予・実 売上高
(百万円)
対前回 修正率 修正率 営業利益
(百万円)
対前回 修正率 修正率 経常利益
(百万円)
対前回 修正率 修正率 当期利益
(百万円)
対前回 修正率 修正率
2026.12 2026/07/31 修正予 2,725,000 ↑ +8.1% +8.1% 469,000 ↑ +30.3% +30.3% 472,000 - - - 355,000 ↑ +34.0% +34.0%
2026.12 2026/04/28 Q1予 2,520,000 → 0.0% 0.0% 360,000 → 0.0% 0.0% - - - - 265,000 → 0.0% 0.0%
2026.12 2026/02/13 当初予 2,520,000 - - - 360,000 - - - - - - - 265,000 - - -
2025.12 2026/02/13 実 2,468,892 ↑ +2.0% +3.7% 479,375 ↑ +6.1% +27.8% - - - - 363,150 ↑ +10.0% +32.1%
2025.12 2025/10/31 Q3予 2,420,000 ↑ +1.7% +1.7% 452,000 ↑ +0.4% +20.5% - - - - 330,000 → 0.0% +20.0%
2025.12 2025/07/31 Q2予 2,380,000 → 0.0% 0.0% 450,000 ↑ +20.0% +20.0% - - - - 330,000 ↑ +20.0% +20.0%
2025.12 2025/04/30 Q1予 2,380,000 → 0.0% 0.0% 375,000 → 0.0% 0.0% - - - - 275,000 → 0.0% 0.0%
2025.12 2025/02/14 当初予 2,380,000 - - - 375,000 - - - - - - - 275,000 - - -
2024.12 2025/02/14 実 2,329,861 ↑ +0.4% +8.9% 323,564 ↓ -3.4% -2.0% - - - - 343,120 ↑ +0.0% +37.2%
2024.12 2025/02/07 修正予 2,320,000 ↑ +0.4% +8.4% 335,000 ↑ +4.7% +1.5% 335,000 - - - 343,000 ↑ +42.9% +37.2%
2024.12 2024/10/31 Q3予 2,310,000 ↓ -0.2% +7.9% 320,000 ↑ +6.0% -3.0% - - - - 240,000 → 0.0% -4.0%
2024.12 2024/08/01 Q2予 2,315,000 ↑ +8.2% +8.2% 302,000 ↓ -8.5% -8.5% - - - - 240,000 ↓ -4.0% -4.0%
2024.12 2024/04/30 Q1予 2,140,000 → 0.0% 0.0% 330,000 → 0.0% 0.0% - - - - 250,000 → 0.0% 0.0%
2024.12 2024/02/14 当初予 2,140,000 - - - 330,000 - - - - - - - 250,000 - - -
2023.12 2024/02/14 実 2,018,568 ↑ +0.0% +12.1% 139,612 ↑ +0.4% -33.5% - - - - 121,616 ↑ +0.5% -22.8%
2023.12 2024/02/13 修正予 2,018,000 ↑ +1.7% +12.1% 139,000 ↓ -43.3% -33.8% 142,000 - - - 121,000 ↓ -35.6% -23.2%
2023.12 2023/10/31 Q3予 1,985,000 ↑ +4.2% +10.3% 245,000 → 0.0% +16.7% - - - - 188,000 → 0.0% +19.4%
2023.12 2023/07/31 Q2予 1,905,000 ↑ +5.8% +5.8% 245,000 ↑ +16.7% +16.7% - - - - 188,000 ↑ +19.4% +19.4%
2023.12 2023/05/12 Q1予 1,800,000 → 0.0% 0.0% 210,000 → 0.0% 0.0% - - - - 157,500 → 0.0% 0.0%
2023.12 2023/02/14 当初予 1,800,000 - - - 210,000 - - - - - - - 157,500 - - -
2022.12 2023/02/14 実 1,737,998 ↑ +1.6% +12.1% 150,323 ↑ +5.9% -21.7% - - - - 134,019 ↑ +2.3% -8.2%
2022.12 2022/10/31 Q3予 1,710,000 ↑ +2.4% +10.3% 142,000 ↓ -6.6% -26.0% - - - - 131,000 ↓ -3.0% -10.3%
2022.12 2022/07/29 Q2予 1,670,000 ↑ +7.7% +7.7% 152,000 ↓ -20.8% -20.8% - - - - 135,000 ↓ -7.5% -7.5%
2022.12 2022/02/10 当初予 1,550,000 - - - 192,000 - - - - - - - 146,000 - - -
2021.12 2022/02/10 実 1,498,276 ↑ +0.0% +5.3% 154,497 ↓ -5.2% -19.5% - - - - 125,463 ↑ +0.4% -14.1%
2021.12 2022/01/27 修正予 1,498,000 ↑ +1.2% +5.3% 163,000 ↓ -19.7% -15.1% 163,000 - - - 125,000 ↓ -22.4% -14.4%
2021.12 2021/11/12 Q3予 1,480,000 → 0.0% +4.0% 203,000 ↓ -2.4% +5.7% - - - - 161,000 ↓ -2.4% +10.3%
2021.12 2021/08/06 Q2予 1,480,000 ↑ +4.0% +4.0% 208,000 ↑ +8.3% +8.3% - - - - 165,000 ↑ +13.0% +13.0%
2021.12 2021/05/13 Q1予 1,423,000 → 0.0% 0.0% 192,000 → 0.0% 0.0% - - - - 146,000 → 0.0% 0.0%
2021.12 2021/02/12 当初予 1,423,000 - - - 192,000 - - - - - - - 146,000 - - -
2020.12 2021/02/12 実 1,422,826 ↑ +0.2% -1.5% 198,582 ↓ -2.2% +0.8% - - - - 148,137 ↓ -1.2% +2.2%
2020.12 2020/11/13 Q3予 1,420,000 ↑ +0.7% -1.7% 203,000 ↑ +0.5% +3.0% 195,000 ↓ -2.5% 0.0% 150,000 → 0.0% +3.4%
2020.12 2020/08/07 Q2予 1,410,000 ↓ -2.4% -2.4% 202,000 ↑ +2.5% +2.5% 200,000 ↑ +2.6% +2.6% 150,000 ↑ +3.4% +3.4%
2020.12 2020/05/28 Q1予 1,445,000 → 0.0% 0.0% 197,000 → 0.0% 0.0% 195,000 → 0.0% 0.0% 145,000 → 0.0% 0.0%
2020.12 2020/02/14 当初予 1,445,000 - - - 197,000 - - - 195,000 - - - 145,000 - - -
2019.12 2020/02/14 実 1,396,240 ↓ -0.3% +0.4% 176,585 ↑ +1.5% +17.7% 173,515 ↑ +2.1% +17.6% 127,151 ↑ +1.7% +15.6%
2019.12 2019/11/12 Q3予 1,400,000 → 0.0% +0.7% 174,000 → 0.0% +16.0% 170,000 → 0.0% +15.3% 125,000 → 0.0% +13.6%
2019.12 2019/08/08 Q2予 1,400,000 ↑ +0.7% +0.7% 174,000 ↑ +16.0% +16.0% 170,000 ↑ +15.3% +15.3% 125,000 ↑ +13.6% +13.6%
2019.12 2019/05/14 Q1予 1,390,000 → 0.0% 0.0% 150,000 → 0.0% 0.0% 147,500 → 0.0% 0.0% 110,000 → 0.0% 0.0%
2019.12 2019/02/13 当初予 1,390,000 - - - 150,000 - - - 147,500 - - - 110,000 - - -
2018.12 2019/02/13 実 1,291,981 ↑ +0.2% -0.6% 108,304 ↓ -14.7% -22.6% 109,497 ↓ -14.5% -20.1% 82,492 ↓ -17.5% -21.4%
2018.12 2018/11/14 Q3予 1,290,000 ↓ -0.8% -0.8% 127,000 ↓ -12.4% -9.3% 128,000 ↓ -12.9% -6.6% 100,000 ↓ -13.0% -4.8%
2018.12 2018/08/08 Q2予 1,300,000 → 0.0% 0.0% 145,000 ↑ +3.6% +3.6% 147,000 ↑ +7.3% +7.3% 115,000 ↑ +9.5% +9.5%
2018.12 2018/05/11 Q1予 1,300,000 → 0.0% 0.0% 140,000 → 0.0% 0.0% 137,000 → 0.0% 0.0% 105,000 → 0.0% 0.0%
2018.12 2018/02/14 当初予 1,300,000 - - - 140,000 - - - 137,000 - - - 105,000 - - -
2017.12 2018/02/14 実 1,239,952 ↓ 0.0% -1.6% 104,181 ↑ +0.2% -13.2% 103,712 ↑ +0.7% -12.8% 112,492 ↑ +0.4% +32.3%
2017.12 2018/02/08 修正予 1,240,000 ↓ -1.6% -1.6% 104,000 ↓ -13.3% -13.3% 103,000 ↓ -13.4% -13.4% 112,000 ↑ +31.8% +31.8%
2017.12 2017/11/14 Q3予 1,260,000 → 0.0% 0.0% 120,000 → 0.0% 0.0% 119,000 → 0.0% 0.0% 85,000 → 0.0% 0.0%
2017.12 2017/08/08 Q2予 1,260,000 → 0.0% 0.0% 120,000 → 0.0% 0.0% 119,000 → 0.0% 0.0% 85,000 → 0.0% 0.0%
2017.12 2017/05/12 Q1予 1,260,000 → 0.0% 0.0% 120,000 → 0.0% 0.0% 119,000 → 0.0% 0.0% 85,000 → 0.0% 0.0%
2017.12 2017/02/14 当初予 1,260,000 - - - 120,000 - - - 119,000 - - - 85,000 - - -
2016.12 2017/02/14 実 1,195,547 ↓ -0.4% -4.4% 101,145 ↓ -12.0% +44.5% 116,680 ↑ +1.5% +45.8% 92,563 ↑ +8.9% +85.1%
2016.12 2016/11/11 Q3予 1,200,000 ↓ -4.0% -4.0% 115,000 ↑ +64.3% +64.3% 115,000 ↑ +43.8% +43.8% 85,000 ↑ +70.0% +70.0%
2016.12 2016/05/13 Q1予 1,250,000 → 0.0% 0.0% 70,000 → 0.0% 0.0% 80,000 → 0.0% 0.0% 50,000 → 0.0% 0.0%
2016.12 2016/02/12 当初予 1,250,000 - - - 70,000 - - - 80,000 - - - 50,000 - - -
2015.12 2016/02/12 実 1,445,227 ↑ +2.5% +5.5% 151,837 ↑ +4.7% +38.0% 159,899 ↑ +6.6% +33.2% 84,086 ↓ -6.6% +5.1%
2015.12 2015/11/13 Q3予 1,410,000 ↑ +2.2% +2.9% 145,000 ↑ +20.8% +31.8% 150,000 ↑ +20.0% +25.0% 90,000 ↑ +12.5% +12.5%
2015.12 2015/08/07 Q2予 1,380,000 ↑ +0.7% +0.7% 120,000 ↑ +9.1% +9.1% 125,000 ↑ +4.2% +4.2% 80,000 → 0.0% 0.0%
2015.12 2015/05/13 Q1予 1,370,000 → 0.0% 0.0% 110,000 → 0.0% 0.0% 120,000 → 0.0% 0.0% 80,000 → 0.0% 0.0%
2015.12 2015/02/13 当初予 1,370,000 - - - 110,000 - - - 120,000 - - - 80,000 - - -
2014.12 2015/02/13 実 1,224,298 ↑ +2.0% +2.0% 196,528 ↑ +3.4% +3.4% 217,210 ↑ +11.4% +11.4% 143,143 ↑ +10.1% +10.1%
2014.12 2014/11/13 Q2予 1,200,000 → 0.0% 0.0% 190,000 → 0.0% 0.0% 195,000 → 0.0% 0.0% 130,000 → 0.0% 0.0%
2014.12 2014/08/08 Q1予 1,200,000 → 0.0% 0.0% 190,000 → 0.0% 0.0% 195,000 → 0.0% 0.0% 130,000 → 0.0% 0.0%
2014.12 2014/05/14 当初予 1,200,000 - - - 190,000 - - - 195,000 - - - 130,000 - - -
2014.03 2014/05/14 実 1,452,759 - - - 198,702 - - - 215,235 - - - 150,989 - - -
シェア ツイート
ページトップへ戻る